期刊文献+

年龄相关性白内障晶状体前囊膜20s蛋白酶体α2亚基表达及意义

Expression and significance of α 2 subunit of 20s proteasome in anterior capsule of lens in patients with age-related cataract
原文传递
导出
摘要 目的年龄相关性白内障(ARC)患者晶状体混浊程度及核的硬度与20s蛋白酶体α2亚基的蛋白表达水平及意义的关系。方法于2015年3月至2016年7月在弋矶山医院眼科收集行超声乳化或小切口白内障摘除术的前囊膜120例(核性60例,皮质性60例)。根据晶状体核的硬度及混浊程度进行分组,核性组分为A组:年轻核,B组:老核;皮质组分为A组:轻度混浊,B组:重度混浊。两种类型白内障中以A组为实验组,B组为对照组;并应用western-blot测定20s蛋白酶体α2亚基在两组ARC患者晶状体前囊膜中的表达水平。结果与A组相比较,B组20s蛋白酶体α2亚基表达水平明显降低,核性(0.99±0,02)VS(0.58±0.08)差异有统计学意义(P〈0.01),皮质性(1.26±0,15)VS(0.89±0.09)差异有统计学意义(P〈0.05)。ARC患者晶状体混浊程度及核的硬度与20s蛋白酶体α2亚基含量呈显著负相关。结论ARC患者前囊膜中20s蛋白酶体α2亚基的蛋白表达含量随晶状体混浊程度及核的硬度加深而降低。 ObjectiveTo identify the relationship between the degree of lens opacity and the hardness of nuclear and the protein expression level of 20s proteasome α2 subunit in age-related cataract patients.MethodsPhacoemulsification or small incision cataract extraction was performed in 120 cases (60 cases of nuclear and 60 cases of cortical) and collected these anterior capsules. According to the degree of hardness and opacity of the lens nucleus, the nucleus was divided into group A: young nucleus, group B: old nuclear; cortical was divided into group A: mild opacity, group B: severe haze. Two types of cataract in group A, group B; and Western-blot was used to determine the 20s proteasome subunit alpha 2 expression levels in two groups of patients with ARC in the anterior lens capsule; experimental research work from July 2015 to March 2016.ResultsCompared with group A, the group B, 20s proteasome subunit α2 expression levels were significantly lower (nuclear (0.99±0.02) VS (0.58±0.08) P 〈0.01, cortical (1.26±0.15) VS (0.89±0.09), P 〈0.05, with the degree of lens opacity and nuclear hardness with the 20s proteasome α2 subunit content in age-related cataract patients was negatively correlated.ConclusionsThe protein expression levels of 20s protein α2 subunit in the anterior capsule of age-related cataract patients decrease with the degree of lens opacity and the hardness of the nucleus.
出处 《中国实用眼科杂志》 2017年第5期533-537,共5页 Chinese Journal of Practical Ophthalmology
基金 皖南医学院附属弋矶山医院引进人才科研基金项目(YR201205)
关键词 年龄相关性白内障 20s蛋白酶体α2亚基 泛素-蛋白酶体途径 前囊膜 Age-related cataract 20s proteasome α2 subunit Ubiquitin proteasome pathway An-terior capsule
  • 相关文献

参考文献1

二级参考文献18

  • 1陈勤,高晨曦,葛礼浩.远志皂苷对脑定位注射Aβ_(1-40)拟AD大鼠脑内神经形态病理学变化的影响[J].激光生物学报,2006,15(3):294-298. 被引量:32
  • 2陈勤,李磊珂.远志皂苷对β淀粉样蛋白1-40诱导的体外培养皮层神经细胞损伤的保护作用[J].中国中药杂志,2007,32(13):1336-1339. 被引量:37
  • 3Estrada LD, Soto C. Disrupting beta-amyloid ag- gregation for Alzheimer's disease treatment [ J ]. Curr Top Med Chem, 2007, 7(1): 115 -126.
  • 4Zhou XW, Li X, Bjorkdahl C, et al. Assessments of the accumulation severities of amyloid beta- protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains [J]. Neurobiol Dis, 2006, 22(3) : 657 -668.
  • 5Awasthi A, Matsunaga Y, Yamada T. Amyloid-be- ta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-be- ta-derived short peptides [ J ]. Exp Neurol, 2005, 196(2) : 282 -289.
  • 6Perry G, Friedman R, Shaw G, et al. Ubiquitin is de- tected in neurofibrillary tangles and senile plaque neurites of Alzheimer's disease brains [ J ]. Proc Natl Acad Sci USA, 1987, 84(9): 3033-3036.
  • 7Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer' s disease[J ]. J Neurochem, 2000, 75(1) : 436 -439.
  • 8Golab J, Bauer TM, Daniel V, et al. Role of the ubiquitin-proteasome pathway in the diagnosis of human diseases[J]. Clin Chem Acta, 2004, 340 (1 -2) : 27 -40.
  • 9Song S, Jung YK. Alzheimer's disease meets the ubiquitin-proteasome system [ J ]. Trends Mol Med, 2004, 10(11) : 565 -570.
  • 10Blurton-Jones M, Laferla FM. Pathways by which Abeta facilitates tau pathology [ J ]. Curr Alzhei- mer Res, 2006, 3(5) : 437 -448.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部